Multi-drug cancer chemotherapy scheduling by a new memetic optimization algorithm
暂无分享,去创建一个
Kwong-Sak Leung | Kin-Hong Lee | Yong Liang | Tony Shu Kam Mok | Sui-Man Tse | K. Leung | Kin-Hong Lee | T. Mok | Yong Liang | Sui-Man Tse
[1] Zbigniew Michalewicz,et al. Genetic algorithms and optimal control problems , 1990, 29th IEEE Conference on Decision and Control.
[2] J. J. Westman,et al. Cancer Treatment Using Multiple Chemotheraputic Agents Subject to Drug Resistance , 2022 .
[3] Urszula Ledzewicz,et al. Optimal Bang-Bang Controls for a Two-Compartment Model in Cancer Chemotherapy , 2002 .
[4] P. Steerenberg,et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. , 2010, Annals of the rheumatic diseases.
[5] José Luiz Boldrini,et al. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy , 2000 .
[6] R. B. Martin,et al. Optimal control drug scheduling of cancer chemotherapy , 1992, Autom..
[7] R. Luus,et al. Multiplicity of solutions in the optimization of a bifunctional catalyst blend in a tubular reactor , 1992 .
[8] John H. Holland,et al. Genetic Algorithms and the Optimal Allocation of Trials , 1973, SIAM J. Comput..
[9] J. J. Westman,et al. Compartmental Model for Cancer Evolution: Chemotherapy and Drug Resistance , 2001 .
[10] Rein Luus,et al. Global optimization of the bifunctional catalyst problem , 1994 .
[11] J. Banga,et al. Dynamic Optimization of Batch Reactors Using Adaptive Stochastic Algorithms , 1997 .
[12] R. Bassanezi,et al. Drug kinetics and drug resistance in optimal chemotherapy. , 1995, Mathematical biosciences.
[13] M. Abundo,et al. Numerical simulation of a stochastic model for cancerous cells submitted to chemotherapy , 1989, Journal of mathematical biology.
[14] Kwong-Sak Leung,et al. Adaptive Elitist-Population Based Genetic Algorithm for Multimodal Function Optimization , 2003, GECCO.
[15] Rein Luus,et al. Iterative dynamic programming programs , 2000 .
[16] Ami Radunskaya,et al. A mathematical tumor model with immune resistance and drug therapy: an optimal control approach , 2001 .
[17] V. Slysh,et al. to 4.4 , 1998 .
[18] R. DeCarlo,et al. Systematic method for determining intravenous drug treatment strategies aiding the humoral immune response , 1998, IEEE Transactions on Biomedical Engineering.
[19] Kwong-Sak Leung,et al. Evolutionary Drug Scheduling Model for Cancer Chemotherapy , 2004, GECCO.
[20] Shea N Gardner,et al. Cell Cycle Phase-Specific CHemotherapy: Computation Methods for Guiding Treatment , 2002, Cell cycle.
[21] Bayliss C. McInnis,et al. Optimal control of bilinear systems: Time-varying effects of cancer drugs , 1979, Autom..
[22] Rein Luus,et al. Iterative dynamic programming , 2019, Iterative Dynamic Programming.
[23] Rein Luus,et al. Optimal control of batch reactors by iterative dynamic programming , 1994 .
[24] J. L. Boldrini,et al. Therapy burden, drug resistance, and optimal treatment regimen for cancer chemotherapy. , 2000, IMA journal of mathematics applied in medicine and biology.